Business Wire

FPT and E.ON Extend Partnership to Drive AI-Powered Energy Management Innovation

11.11.2025 02:00:00 CET | Business Wire | Press release

Share

Global technology and IT services provider FPT and E.ON Optimum, the digital solutions arm of E.ON UK, under E.ON Group, announced a new agreement to extend their collaboration in digital energy management. The signing marks the next phase of a partnership established in 2022, reaffirming both corporations’ shared vision of harnessing technology to accelerate innovation and sustainability in the energy sector.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110039775/en/

FPT and E.ON Optimum leaders at the signing ceremony to extend their partnership in AI-powered energy management.

Under this agreement, FPT will continue to support the development and operation of E.ON Optimum’s solution platform, a cloud-based energy management system that gives business energy users timely, flexible data analysis, allowing for better and faster decisions on net-zero energy usage.

The next phase focuses on maintaining and enhancing web application features, as well as applying FPT’s proprietary AI technology to forecast energy consumption and pricing. The collaboration also opens opportunities for broader technology engagement with E.ON, strengthening both sides’ efforts toward digital innovation and green energy management.

Over the past three years, FPT has played a pivotal role in developing and operating the Optimum platform end-to-end, from web application development and architecture design to feature maintenance and AI/ML-based consumption forecasting using weather data. This collaboration has strengthened E.ON’s digital capabilities and elevated customer experience across the UK and wider European regions.

“Our collaboration with E.ON Optimum and the wider E.ON Group reflects FPT’s commitment to pioneering digital transformation across the global energy landscape,” said Dzung Tran, FPT Software Senior Vice President and FPT Europe Chief Executive Officer, FPT Corporation. “By integrating our expertise in AI, Cloud, Data Platforms, and Grid Management, we are co-creating the solutions that enhance operational efficiency and sustainability. Together, we look forward to expanding our partnership to help E.ON achieve their goals, accelerate the energy transition, and build a more resilient future.”

"Working with FPT in our development of the Optimum product has brought fresh energy and innovation to our digital products.” Jamie Rodd, Head of Optimum Digital Product at E.ON Optimum, stated. “Their agile approach and technical expertise have enabled us to deliver faster, smarter solutions that directly benefit our customers. We've seen improved user satisfaction and engagement thanks to the enhancements they helped us implement. As a new service provider, they’ve shown impressive adaptability and a genuine commitment to our success, consistently delivering with professionalism and flexibility, adapting quickly to our evolving needs. We’re excited to see how they continue to grow and push boundaries."

This signing builds on an extensive collaboration between FPT and E.ON across SAP, ServiceNow, Sitecore, DevOps, Application Development, Testing, and Cloud. The two corporations have jointly delivered large-scale projects, including SAP authorization for over 60,000 users across Europe, and supported E.ON One in advancing sustainable energy solutions. In 2023, both sides further strengthened their partnership by exploring the establishment of a delivery center in Vietnam to enhance operational resilience, agility, and global delivery capacity.

About FPT

FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam and operates in three core sectors: Technology, Telecommunications, and Education. Over more than three decades, FPT has consistently delivered impactful solutions to millions of individuals and tens of thousands of organizations worldwide. As an AI-first company, FPT is committed to elevating Vietnam’s position on the global tech map and delivering world-class AI-enabled solutions for global enterprises. FPT focuses on three critical transformations: Digital Transformation, Intelligence Transformation, and Green Transformation. In 2024, FPT reported a total revenue of USD 2.47 billion and a workforce of over 54,000 employees across its core businesses. For more information about FPT's global IT services, please visit https://fptsoftware.com.

About E.ON UK

E.ON's goal is to ensure the energy transition works for everyone. Through E.ON Next, E.ON Energy Infrastructure Solutions and npower Business Solutions, our mission is to help make energy more affordable and sustainable across homes, businesses, cities and communities. Globally, E.ON is a major provider of energy solutions and clean energy networks with around 47 million customers across 17 countries. In the UK, we serve nearly one in seven households and businesses, and we are the UK's largest supplier of electricity to industrial clients.

www.eonenergy.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251110039775/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye